Volume 19, Number 6—June 2013
Research
Effect of Travel on Influenza Epidemiology
Table 1
Characteristic | Travelers at risk, no. (%) | Travelers with infection† |
Person-months of travel | IR, %‡ (95% CI) | Univariable analysis |
Multivariable analysis |
||||
---|---|---|---|---|---|---|---|---|---|---|
No. | AR, % (95% CI) | IRR (95% CI) | p value | IRR (95% CI) | p value | |||||
All | 1,190 (100) | 86 | 7.2 (5.9–8.8) | 969 | 8.9 (7.1–10.9) | |||||
Sex | ||||||||||
M | 510 (43) | 31 | 6.1 (4.2–8.4) | 404 | 7.7 (5.3–10.8) | 1.0 | 0.286 | |||
F | 680 (57) | 55 | 8.1 (6.2–10.4) | 565 | 9.7 (7.4–12.6) | 1.3 (0.8–2.0) | ||||
Age group, y | ||||||||||
<25 | 140 (12) | 8 | 5.7 (2.7–10.6) | 151 | 5.3 (2.5–10.1) | 1.00 | 0.098 | 1.0 | ||
25–34 | 381 (32) | 22 | 5.8 (3.8–8.5) | 315 | 7.0 (4.5–10.4) | 1.3 (0.6–3.0) | 1.3 (0.6–2.9) | 0.558 | ||
35–44 | 223 (19) | 21 | 9.4 (6.1–13.8) | 168 | 12.5 (7.9–18.8) | 2.4 (1.0–5.3) | 2.2 (1.0–4.9) | 0.063 | ||
45–54 | 226 (19) | 13 | 5.8 (3.2–9.4) | 165 | 7.9 (4.4–13.1) | 1.5 (0.6–3.6) | 1.3 (0.5–3.2) | 0.538 | ||
55–64 | 165 (14) | 17 | 10.3 (6.3–15.7) | 124 | 13.7 (8.3–21.5) | 2.6 (1.1–6.0) | 2.6 (1.1–6.1) | 0.025 | ||
>65 | 55 (5) | 5 | 9.1 (3.4–19.0) | 46 | 10.9 (4.0–24.1) | 2.1 (0.7–6.3) | 1.9 (0.6–5.8) | 0.259 | ||
Region of birth | ||||||||||
Western | 1,103 (93) | 72 | 6.5 (5.2–8.1) | 905 | 8.0 (6.3–10.0) | 1.0 | 0.006 | 1.0 | ||
Nonwestern | ||||||||||
Africa | 12 (1) | 3 | 25.0 (6.8–54.1) | 11 | 27.3 (6.9–74.2) | 3.4 (1.1–10.8) | 3.7 (1.2–11.9) | 0.029 | ||
Latin America | 47 (4) | 9 | 19.1 (9.8–32.2) | 31 | 29.0 (14.2–53.3) | 3.7 (1.8–7.4) | 3.8 (1.9–7.8) | <0.001 | ||
Asia | 28 (2) | 2 | 7.1 (1.2–21.7) | 22 | 9.1 (1.5–30.0) | 1.1 (0.3–4.6) | 1.1 (0.3–4.4) | 0.926 | ||
Previous travel to(sub)tropical country | ||||||||||
Never | 224 (19) | 11 | 4.9 (2.6–8.4) | 180 | 6.1 (3.2–10.6) | 1.0 | 0.140 | |||
1–5 times | 687 (58) | 49 | 7.1 (5.4–9.2) | 573 | 8.6 (6.4–11.2) | 1.4 (0.7–2.7) | ||||
>6 times | 279 (23) | 26 | 9.3 (6.3–13.2) | 217 | 12.0 (8.0–17.3) | 2.0 (1.0–4.0) | ||||
Primary purpose of travel | ||||||||||
Tourism | 1,017 (85) | 73 | 7.2 (5.7–8.9) | 826 | 8.8 (7.0–11.1) | 1.0 | 1.000 | |||
Work or education | 100 (8) | 8 | 8 (3.8–14.6) | 86 | 9.3 (4.3–17.7) | 1.1 (0.5–2.2) | ||||
Visiting friends and/or relatives | 73 (6) | 5 | 6.9 (2.6–14.5) | 57 | 8.8 (3.2–19.4) | 1.0 (0.4–2.4) | ||||
Travel destination | ||||||||||
Latin America | ||||||||||
South America | 202 (17) | 13 | 6.4 (3.6–10.5) | 167 | 7.8 (4.3–13.0) | 1.0 | 0.373 | |||
Central America and Caribbean | 120 (10) | 9 | 7.5 (3.7–13.3) | 78 | 11.5 (5.6–21.2) | 1.5 (0.7–3.5) | ||||
Africa | ||||||||||
Southern and Eastern Africa | 181 (15) | 12 | 6.6 (3.6–11) | 147 | 8.2 (4.4–13.9) | 1.1 (0.5–2.3) | ||||
Middle, Western, Northern Africa | 110 (9) | 10 | 9.1 (4.7–15.6) | 75 | 13.3 (6.8–23.8) | 1.7 (0.8–3.9) | ||||
Asia | ||||||||||
Southeastern and Eastern Asia | 416 (35) | 25 | 6.0 (4.0–8.6) | 365 | 6.9 (4.5–10.0) | 0.9 (0.5–1.7) | ||||
South-central and Western Asia | 125 (11) | 14 | 11.2 (6.5–17.7) | 97 | 14.4 (8.2–23.6) | 1.9 (0.9–4.0) | ||||
More regions | 33 (3) | 3 | 9.1 (2.4–22.8) | 37 | 8.1 (2.1–22.1) | 1.1 (0.3–3.7) | ||||
More continents | 3 (<1) | 0 | 0 | |||||||
Symptoms | ||||||||||
Fever | ||||||||||
No | 1,073 (90) | 71 | 6.6 (5.2–8.2) | 854 | 8.3 (6.5–10.4) | 1.0 | 0.131 | |||
Yes | 117 (10) | 15 | 12.8 (7.6–19.8) | 115 | 13.0 (7.6–21.0) | 1.6 (0.9–2.7) | ||||
ILI§ | ||||||||||
No | 1,150 (97) | 77 | 6.7 (5.4–8.3) | 930 | 8.3 (6.6–10.3) | 1.0 | 0.010 | 1.0 | 0.004 | |
Yes | 40 (3) | 9 | 22.5 (11.6–37.3) | 38 | 23.7 (11.6–43.5) | 2.8 (1.4–5.7) | 2.8 (1.4–5.5) |
*AR, attack rate; IR, incidence rate; IRR, incidence rate ratio; ILI, influenza-like illness. Boldface indicates significance (p<0.05).
†Travelers with confirmed influenza infection for >1 influenza virus.
‡Per 100 person-months.
§Travelers with ILI are a subgroup of travelers with fever.
Page created: May 09, 2013
Page updated: May 09, 2013
Page reviewed: May 09, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.